[Severe late dyskinesia caused by neuroleptics in a young female. Follow-up and treatment].
Diedrich
U
U
Abteilung Psychiatrie, Universität Göttingen.
Müller
P
P
D000293:Adolescent; D002220:Carbamazepine / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D002504:Meclofenoxate / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use
D002220:Carbamazepine; D002504:Meclofenoxate; D003024:Clozapine; D006220:Haloperidol; D013976:Tiapamil Hydrochloride
Schwere Spätdyskinesie durch Neuroleptika bei einer jungen Frau. Verlauf und Behandlung.